tiprankstipranks
Advertisement
Advertisement

SYRE Stock Latest News

Spyre Therapeutics price target raised to $102 from $86 at Deutsche Bank
The FlySpyre Therapeutics price target raised to $102 from $86 at Deutsche Bank
6d ago
SYRE
Spyre Therapeutics price target raised to $97 from $64 at Citi
PremiumThe Fly
Spyre Therapeutics price target raised to $97 from $64 at Citi
11d ago
SYRE
Spyre Therapeutics price target raised to $107 from $92 at Stifel
PremiumThe Fly
Spyre Therapeutics price target raised to $107 from $92 at Stifel
11d ago
SYRE
Julian Harrison Reiterates Buy on Spyre Therapeutics, Maintains $98 Price Target on Strong IBD Pipeline and Cash Runway
PremiumRatings
Julian Harrison Reiterates Buy on Spyre Therapeutics, Maintains $98 Price Target on Strong IBD Pipeline and Cash Runway
12d ago
SYRE
Spyre Therapeutics’ Exclusive Forum Clauses Shift Legal Leverage, Raise Venue and Litigation Cost Concerns for Stockholders
PremiumCompany Announcements
Spyre Therapeutics’ Exclusive Forum Clauses Shift Legal Leverage, Raise Venue and Litigation Cost Concerns for Stockholders
12d ago
SYRE
Spyre Therapeutics reports Q1 EPS (74c), consensus (65c)
PremiumThe FlySpyre Therapeutics reports Q1 EPS (74c), consensus (65c)
13d ago
SYRE
Spyre Therapeutics: Buy Rating Reaffirmed as External Combo Data Support IBD Strategy; $95 Price Target Unchanged
Premium
Ratings
Spyre Therapeutics: Buy Rating Reaffirmed as External Combo Data Support IBD Strategy; $95 Price Target Unchanged
18d ago
SYRE
Spyre Therapeutics price target raised to $95 from $64 at JonesResearch
Premium
The Fly
Spyre Therapeutics price target raised to $95 from $64 at JonesResearch
1M ago
SYRE
Spyre Therapeutics Raises Capital Through Completed Stock Offering
PremiumCompany Announcements
Spyre Therapeutics Raises Capital Through Completed Stock Offering
1M ago
8K
SYRE
3 Best Trending Stocks, According to Analysts – 4/16/2026
PremiumMarket News
3 Best Trending Stocks, According to Analysts – 4/16/2026
1M ago
AMZN
GSAT
Spyre Therapeutics 6.5M share Secondary priced at $62.00
PremiumThe Fly
Spyre Therapeutics 6.5M share Secondary priced at $62.00
1M ago
SYRE
Spyre Therapeutics price target raised to $90 from $65 at Baird
PremiumThe Fly
Spyre Therapeutics price target raised to $90 from $65 at Baird
1M ago
SYRE
Spyre Therapeutics price target raised to $90 from $50 at Wells Fargo
PremiumThe FlySpyre Therapeutics price target raised to $90 from $50 at Wells Fargo
1M ago
SYRE
Spyre Therapeutics price target raised to $88 from $55 at Deutsche Bank
Premium
The Fly
Spyre Therapeutics price target raised to $88 from $55 at Deutsche Bank
1M ago
SYRE
Closing Bell Movers: Bloom Energy spikes on expanded Oracle deal
Premium
The Fly
Closing Bell Movers: Bloom Energy spikes on expanded Oracle deal
1M ago
C
BE
Spyre Therapeutics announces $300M offering of common stock
PremiumThe Fly
Spyre Therapeutics announces $300M offering of common stock
1M ago
SYRE
Spyre Therapeutics Pauses At-The-Market Equity Offering Program
PremiumCompany Announcements
Spyre Therapeutics Pauses At-The-Market Equity Offering Program
1M ago
8K
SYRE
Spyre Therapeutics initiated with a Strong Buy at Raymond James
PremiumThe Fly
Spyre Therapeutics initiated with a Strong Buy at Raymond James
1M ago
SYRE
Buy Rating on SYRE: Early SPY001 Outperformance, Broad IBD Opportunity, and Catalyst‑Rich Path Support Higher $80 Target
PremiumRatings
Buy Rating on SYRE: Early SPY001 Outperformance, Broad IBD Opportunity, and Catalyst‑Rich Path Support Higher $80 Target
1M ago
SYRE
Spyre Therapeutics price target raised to $80 from $65 at Wedbush
PremiumThe FlySpyre Therapeutics price target raised to $80 from $65 at Wedbush
1M ago
TAK
SYRE
Spyre data ‘exceptional,’ but combos could enable ‘dominance,’ says TD Cowen
Premium
The Fly
Spyre data ‘exceptional,’ but combos could enable ‘dominance,’ says TD Cowen
1M ago
SYRE
Spyre Therapeutics price target raised to $106 from $49 at Leerink
Premium
The Fly
Spyre Therapeutics price target raised to $106 from $49 at Leerink
1M ago
SYRE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >